Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of TL118 in pediatric patients with NTRK fusion-positive advanced solid tumors or primary CNS tumors
CTR20253321Phase 2Active
- Sponsor
- Taolue Biopharma
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TL118 in Nonhematologic neoplasms, central nervous system tumor, sponsored by Taolue Biopharma. Started Aug 2025; status: active.
02
Drugs
TL118
03
Conditions
Nonhematologic neoplasmscentral nervous system tumor
Beyond the preview
Go deeper on CTR20253321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253321.